USPTO serial 79158159
CENTOMD
Reviewed by CopyMark Law Group
Reg. 4995243Status 404
- Filing date
- Status date
- Registration date
- Jul 12, 2016
- Examiner
- LAM, HAI-LY HUYNH
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CENTOMD?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Angela P. Doughty
ANGELA P. DOUGHTY WARD AND SMITH, P.A.1001 COLLEGE COURTNEW BERN, NC 28562UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for hereditary diseases, metabolic diseases, oncological diseases, complex multigenic diseases and veterinary preparations for hereditary diseases, metabolic diseases, oncological diseases, complex multigenic diseases; diagnostic preparations for medical or veterinary purposes, namely, for detecting hereditary diseases via DNA sequencing or detecting other genetic lesions especially on multiple genes or the whole genomic coding region or the whole genome, for detecting DNA lesions in somatic samples, for biochemical analysis of biological samples, for analysis of predisposition for genetically driven disorders, prediction and monitoring of treatment response in a clinical laboratory all for medical or veterinary purposes; chemical preparations for analyses in laboratories, for medical or veterinary purposes, namely, nucleic acid and chemical reagents; biological preparations for medical purposes, namely, for the treatment of hereditary diseases, metabolic diseases, oncological diseases and complex multigenic diseases | SECTION 71 - CANCELLED | — |
| 009 | Scientific, surveying, weighing, measuring and checking apparatus and instruments, namely, fluorometers, spectrophotometers, real-time PCR devices for gene expression and genotyping, DNA analyzers, DNA fragmentation and capture devices, thermal cycler, and thermal blocks for incubations all to determine the structure, composition or sequence of DNA on multiple genes or on the whole genomic coding region or the whole genome, to determine structure, composition or sequence of RNA and for biochemical measurements of biomarkers; apparatus and instruments for scientific research in laboratories, namely, scientific devices to determine DNA or RNA sequence, alterations, rearrangements, copy number variations, and deletions; devices to determine biochemical markers, namely, fluorometers, spectrophotometers, real-time PCR devices for gene expression and genotyping, DNA analyzers, and DNA fragmentation and capture devices all for scientific purposes; devices to prepare respective biological samples for acquiring measurements, namely, thermal cyclers, thermal blocks, magnetic beads, pipetting tips, microcentrifuge tubes, and 96-well microplates; pre-recorded compact discs, DVDs, downloadable audio and video digital recordings, and digital video discs, all featuring clinical phenotypic, genetic molecular and demographic information; computers; computer software for database management and for managing, analyzing, interpreting and storing the data obtained from laboratory instruments | SECTION 71 - CANCELLED | — |
| 035 | Compilation and systematic ordering of data in a computer database; computerised file management especially for data coming from DNA analysis from multiple genes or the genomic coding region or the whole genome | SECTION 71 - CANCELLED | — |
| 042 | Scientific and technological services, namely, genetic and biochemical analytical testing for scientific research purposes and new product research and design relating thereto; industrial analysis and research services in the field of genetics and in the field of pharmaceutical development; scientific research for medical purposes in the field of hereditary diseases, oncology, and complex genetics related diseases; design and development of computer hardware and computer software that support the processing and analysis of complex genomic data; medical research laboratory services | SECTION 71 - CANCELLED | — |
| 044 | Medical services, in particular medical analysis in connection with the treatment of individuals; providing information in the fields of medicine, veterinary medicine and pharmaceuticals; health centers, namely, genetic centers providing medical diagnostic, preventive and curative therapy services for genetic disorders, cancer treatment centers, rare disease treatment centers, children's hospitals and women's hospital; medical clinics; gene therapy services in the field of oncology, infertility, prenatal diagnostics, carrier testing, and genetically inherited diseases; medical laboratory services for the analysis of samples taken from patients, namely, medical testing of blood, tissue, saliva, urine, and hair follicle | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Centogene AG
- Other trademarks owned by Centogene AG
- Other trademarks owned by Centogene GmbH
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 035
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named CENTOMD
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 21, 2025 | DENA | NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED | — |
| Feb 21, 2025 | DETH | DEATH OF INTERNATIONAL REGISTRATION | — |
| Oct 23, 2023 | INNT | TOTAL INVALIDATION PROCESSED BY THE IB | — |
| Sep 30, 2023 | INTS | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Sep 30, 2023 | INPC | INVALIDATION PROCESSED | — |
| Sep 27, 2023 | INTR | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jan 27, 2023 | C71T | CANCELLED SECTION 71 | — |
| Jul 12, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Sep 18, 2020 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 26, 2018 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Oct 15, 2016 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 12, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 12, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 17, 2016 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 1, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 1, 2016 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Apr 26, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 26, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 6, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 6, 2016 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Apr 6, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 18, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Mar 16, 2016 | ALIE | ASSIGNED TO LIE | — |
| Mar 15, 2016 | EXPT | EXPARTE APPEAL TERMINATED | — |
| Mar 15, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 23, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 23, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 23, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 23, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 10, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 10, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 5, 2016 | ALIE | ASSIGNED TO LIE | — |
| Jan 27, 2016 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Jan 27, 2016 | EXPI | EX PARTE APPEAL-INSTITUTED | — |
| Jan 27, 2016 | JURT | JURISDICTION RESTORED TO EXAMINING ATTORNEY | — |
| Jan 27, 2016 | EXAF | EXPARTE APPEAL RECEIVED AT TTAB | — |
| Jul 28, 2015 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Jul 28, 2015 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 28, 2015 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 9, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 8, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 8, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 31, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 13, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 13, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jan 13, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 12, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jan 11, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 7, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 7, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 2, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |